Corticosteroid therapy for rheumatoid arthritis.
D000305:Adrenal Cortex Hormones / Q000266:history / Q000627:therapeutic use*; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001284:Atrophy / Q000139:chemically induced; D001623:Betamethasone / Q000627:therapeutic use; D004347:Drug Interactions; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D049673:History, 20th Century; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007239:Infections / Q000139:chemically induced; D007270:Injections, Intra-Articular / Q000009:adverse effects; D007592:Joint Diseases; D008775:Methylprednisolone / Q000627:therapeutic use; D009336:Necrosis / Q000139:chemically induced; D010024:Osteoporosis / Q000139:chemically induced; D010437:Peptic Ulcer / Q000139:chemically induced; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012216:Rheumatic Diseases / Q000139:chemically induced; D012459:Salicylates / Q000009:adverse effects; D012871:Skin Diseases / Q000139:chemically induced; D013375:Substance Withdrawal Syndrome; D013585:Synovitis / Q000139:chemically induced; D014221:Triamcinolone / Q000627:therapeutic use; D014652:Vascular Diseases / Q000139:chemically induced
D000305:Adrenal Cortex Hormones; D005938:Glucocorticoids; D012459:Salicylates; D014221:Triamcinolone; D000324:Adrenocorticotropic Hormone; D001623:Betamethasone; D011239:Prednisolone; D011241:Prednisone; D006854:Hydrocortisone; D008775:Methylprednisolone